Multicenter clinical evaluation of the automated Aries Bordetella assay

Ryan Relich, Amy Leber, Stephen Young, Ted Schutzbank, Ronald Dunn, Janet Farhang, Timothy S. Uphoff

Research output: Contribution to journalArticle

Abstract

Molecular methods offer superior sensitivity and specificity and reduce testing turnaround time from days to hours for detection of Bordetella pertussis and Bordetella parapertussis. In this study, we evaluated the performance of the automated PCR-based Aries Bordetella Assay, which detects both B. pertussis and B. parapertussis directly from nasopharyngeal swab specimens. The limits of detection (LoDs) were 1,800 CFU·ml- 1 for B. pertussis and 213 CFU·ml- 1 for B. parapertussis. The assay detected 16/18 unique B. pertussis/B. parapertussis strains. Of 71 potentially cross-reacting organisms, 5 generated false positives in 1/6 replicates; none of 6 additional Bordetella spp. were erroneously detected. Specimens were stable at 20 to 25°C for at least 10 h, at 4 to 8°C for 10 days, and at temperatures not exceeding -70°C for 6 months. Of 1,052 nasopharyngeal specimens from patients with suspected pertussis, 3.0% (n = 32) were B. pertussis positive and 0.2% (n = 2) were B. parapertussis positive. Combining these data with Aries Bordetella Assay data from 57 nasopharyngeal samples with previously confirmed B. pertussis or B. parapertussis data and with data from 50 contrived B. parapertussis samples, the proportions of positive and negative agreement of the respective Aries assays with the reference assays were 97.1% and 99.0% for B. pertussis and 100% and 99.7% for B. parapertussis. The Aries Bordetella Assay provides accurate detection and distinction of B. pertussis and B. parapertussis infections within 2 h. (This study has been registered at ClinicalTrials.gov under registration no. NCT02862262).

Original languageEnglish (US)
Article numbere01471
JournalJournal of clinical microbiology
Volume57
Issue number2
DOIs
StatePublished - Feb 1 2019

Fingerprint

Bordetella parapertussis
Bordetella
Bordetella pertussis
Bordetella Infections
Whooping Cough
Limit of Detection

Keywords

  • Bordetella parapertussis
  • Bordetella pertussis
  • PCR
  • Pertussis
  • Whooping cough

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Relich, R., Leber, A., Young, S., Schutzbank, T., Dunn, R., Farhang, J., & Uphoff, T. S. (2019). Multicenter clinical evaluation of the automated Aries Bordetella assay. Journal of clinical microbiology, 57(2), [e01471]. https://doi.org/10.1128/JCM.01471-18

Multicenter clinical evaluation of the automated Aries Bordetella assay. / Relich, Ryan; Leber, Amy; Young, Stephen; Schutzbank, Ted; Dunn, Ronald; Farhang, Janet; Uphoff, Timothy S.

In: Journal of clinical microbiology, Vol. 57, No. 2, e01471, 01.02.2019.

Research output: Contribution to journalArticle

Relich, R, Leber, A, Young, S, Schutzbank, T, Dunn, R, Farhang, J & Uphoff, TS 2019, 'Multicenter clinical evaluation of the automated Aries Bordetella assay', Journal of clinical microbiology, vol. 57, no. 2, e01471. https://doi.org/10.1128/JCM.01471-18
Relich, Ryan ; Leber, Amy ; Young, Stephen ; Schutzbank, Ted ; Dunn, Ronald ; Farhang, Janet ; Uphoff, Timothy S. / Multicenter clinical evaluation of the automated Aries Bordetella assay. In: Journal of clinical microbiology. 2019 ; Vol. 57, No. 2.
@article{d085d8522c02444fa297674e4f509022,
title = "Multicenter clinical evaluation of the automated Aries Bordetella assay",
abstract = "Molecular methods offer superior sensitivity and specificity and reduce testing turnaround time from days to hours for detection of Bordetella pertussis and Bordetella parapertussis. In this study, we evaluated the performance of the automated PCR-based Aries Bordetella Assay, which detects both B. pertussis and B. parapertussis directly from nasopharyngeal swab specimens. The limits of detection (LoDs) were 1,800 CFU·ml- 1 for B. pertussis and 213 CFU·ml- 1 for B. parapertussis. The assay detected 16/18 unique B. pertussis/B. parapertussis strains. Of 71 potentially cross-reacting organisms, 5 generated false positives in 1/6 replicates; none of 6 additional Bordetella spp. were erroneously detected. Specimens were stable at 20 to 25°C for at least 10 h, at 4 to 8°C for 10 days, and at temperatures not exceeding -70°C for 6 months. Of 1,052 nasopharyngeal specimens from patients with suspected pertussis, 3.0{\%} (n = 32) were B. pertussis positive and 0.2{\%} (n = 2) were B. parapertussis positive. Combining these data with Aries Bordetella Assay data from 57 nasopharyngeal samples with previously confirmed B. pertussis or B. parapertussis data and with data from 50 contrived B. parapertussis samples, the proportions of positive and negative agreement of the respective Aries assays with the reference assays were 97.1{\%} and 99.0{\%} for B. pertussis and 100{\%} and 99.7{\%} for B. parapertussis. The Aries Bordetella Assay provides accurate detection and distinction of B. pertussis and B. parapertussis infections within 2 h. (This study has been registered at ClinicalTrials.gov under registration no. NCT02862262).",
keywords = "Bordetella parapertussis, Bordetella pertussis, PCR, Pertussis, Whooping cough",
author = "Ryan Relich and Amy Leber and Stephen Young and Ted Schutzbank and Ronald Dunn and Janet Farhang and Uphoff, {Timothy S.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1128/JCM.01471-18",
language = "English (US)",
volume = "57",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Multicenter clinical evaluation of the automated Aries Bordetella assay

AU - Relich, Ryan

AU - Leber, Amy

AU - Young, Stephen

AU - Schutzbank, Ted

AU - Dunn, Ronald

AU - Farhang, Janet

AU - Uphoff, Timothy S.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Molecular methods offer superior sensitivity and specificity and reduce testing turnaround time from days to hours for detection of Bordetella pertussis and Bordetella parapertussis. In this study, we evaluated the performance of the automated PCR-based Aries Bordetella Assay, which detects both B. pertussis and B. parapertussis directly from nasopharyngeal swab specimens. The limits of detection (LoDs) were 1,800 CFU·ml- 1 for B. pertussis and 213 CFU·ml- 1 for B. parapertussis. The assay detected 16/18 unique B. pertussis/B. parapertussis strains. Of 71 potentially cross-reacting organisms, 5 generated false positives in 1/6 replicates; none of 6 additional Bordetella spp. were erroneously detected. Specimens were stable at 20 to 25°C for at least 10 h, at 4 to 8°C for 10 days, and at temperatures not exceeding -70°C for 6 months. Of 1,052 nasopharyngeal specimens from patients with suspected pertussis, 3.0% (n = 32) were B. pertussis positive and 0.2% (n = 2) were B. parapertussis positive. Combining these data with Aries Bordetella Assay data from 57 nasopharyngeal samples with previously confirmed B. pertussis or B. parapertussis data and with data from 50 contrived B. parapertussis samples, the proportions of positive and negative agreement of the respective Aries assays with the reference assays were 97.1% and 99.0% for B. pertussis and 100% and 99.7% for B. parapertussis. The Aries Bordetella Assay provides accurate detection and distinction of B. pertussis and B. parapertussis infections within 2 h. (This study has been registered at ClinicalTrials.gov under registration no. NCT02862262).

AB - Molecular methods offer superior sensitivity and specificity and reduce testing turnaround time from days to hours for detection of Bordetella pertussis and Bordetella parapertussis. In this study, we evaluated the performance of the automated PCR-based Aries Bordetella Assay, which detects both B. pertussis and B. parapertussis directly from nasopharyngeal swab specimens. The limits of detection (LoDs) were 1,800 CFU·ml- 1 for B. pertussis and 213 CFU·ml- 1 for B. parapertussis. The assay detected 16/18 unique B. pertussis/B. parapertussis strains. Of 71 potentially cross-reacting organisms, 5 generated false positives in 1/6 replicates; none of 6 additional Bordetella spp. were erroneously detected. Specimens were stable at 20 to 25°C for at least 10 h, at 4 to 8°C for 10 days, and at temperatures not exceeding -70°C for 6 months. Of 1,052 nasopharyngeal specimens from patients with suspected pertussis, 3.0% (n = 32) were B. pertussis positive and 0.2% (n = 2) were B. parapertussis positive. Combining these data with Aries Bordetella Assay data from 57 nasopharyngeal samples with previously confirmed B. pertussis or B. parapertussis data and with data from 50 contrived B. parapertussis samples, the proportions of positive and negative agreement of the respective Aries assays with the reference assays were 97.1% and 99.0% for B. pertussis and 100% and 99.7% for B. parapertussis. The Aries Bordetella Assay provides accurate detection and distinction of B. pertussis and B. parapertussis infections within 2 h. (This study has been registered at ClinicalTrials.gov under registration no. NCT02862262).

KW - Bordetella parapertussis

KW - Bordetella pertussis

KW - PCR

KW - Pertussis

KW - Whooping cough

UR - http://www.scopus.com/inward/record.url?scp=85060910244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060910244&partnerID=8YFLogxK

U2 - 10.1128/JCM.01471-18

DO - 10.1128/JCM.01471-18

M3 - Article

C2 - 30518543

AN - SCOPUS:85060910244

VL - 57

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 2

M1 - e01471

ER -